The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing
Open accessAbstract
Single-cell RNA-sequencing (scRNA-seq) presents better insights into cell behavior in the context of a complex tumor microenvironment by profiling single-cell populations. However, the mechanisms underlying treatment failure in hepatocellular carcinoma (HCC) are poorly understood. In this study, we performed deep scRNA-seq on immune cells under the isolation in peripheral blood, cancer tissues, and nearby common tissues of four HCC cases and two non-cancer controls, and 212,494 cells were included in the analysis. We identified distinct immune cell subtypes, enriched pathways for differential genes, and delineated associated developmentally relevant trajectories. APOC1 was found over-expressed in tumor-associated macrophages (TAMs) of HCC tissues than in normal tissues. Inhibition of APOC1 reversed the M2 phenotype to the M1 phenotype via the ferroptosis pathway in TAMs from HCC. Tumors in APOC1 −/− C57BL/6 mice demonstrated consistent attenuation compared to wild-type (WT) mice. Mass spectrometry results revealed that the relative proportion of M2 macrophages, B cells, and CD4+ T cells in the APOC1 −/− group exhibited a downward expression compared with the WT group, whereas CD8+ T cells, M1 macrophages, and NK cells exhibited an upward trend. Finally, APOC1 was found to be negatively correlated with the expression of PD1/PD-L1 in human HCC samples. In conclusion, the present study demonstrated that inhibiting APOC1 can promote the transformation of M2 macrophages into M1 macrophages via the ferroptosis pathway, thereby reshaping the tumor immune microenvironment and improving the anti-PD1 immunotherapy for HCC, providing a new strategy for improving the therapeutic effect of anti-PD1, and bringing new hope to HCC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T.-Y., Kudo, M., Breder, V., Merle, P., Kaseb, A. O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915745 · Cited by 7,470
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
mRNA-Seq whole-transcriptome analysis of a single cell
Tang, F., Barbacioru, C., Wang, Y., Nordman, E., Lee, C., Xu, N., Wang, X., Bodeau, J., Tuch, B. B., Siddiqui, A., et al. (2009) · Nature Methods · doi:10.1038/nmeth.1315 · Cited by 3,969
Self-citationTlr signalling augments macrophage bactericidal activity through mitochondrial ros
West, A. P., Brodsky, I. E., Rahner, C., Woo, D. K., Erdjument-Bromage, H., Tempst, P., Walsh, M. C., Choi, Y., Shadel, G. S., & Ghosh, S. (2011) · Nature · doi:10.1038/nature09973 · Cited by 1,659
Yau, T., Park, J.-W., Finn, R. S., Cheng, A.-L., Mathurin, P., Edeline, J., Kudo, M., Harding, J. J., Merle, P., Rosmorduc, O., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00604-5 · Cited by 1,106
The immunology of hepatocellular carcinoma
Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E., & Heikenwalder, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0044-z · Cited by 1,076
Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W. J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R., Weber, J. S., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz011 · Cited by 945
Yau, T. (., Park, J. W. (.-W., Finn, R. S. (. S. )., Cheng, A. L. (.-L., Mathurin, P., Edeline, J., Kudo, M. (., Harding, J. J., Merle, P., Rosmorduc, O., et al. (2022) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · Cited by 934
ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–
Wang, L., Liu, Y., Du, T., Yang, H., Lei, L., Guo, M., Ding, H.-F., Zhang, J., Wang, H., Chen, X., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0380-z · Cited by 809
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
Luoma, A. M., Suo, S., Williams, H. L., Sharova, T., Sullivan, K., Manos, M., Bowling, P., Hodi, F. S., Rahma, O., Sullivan, R. J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.001 · Cited by 484
Bone marrow and the control of immunity
Zhao, E., Xu, H., Wang, L., Kryczek, I., Wu, K., Hu, Y., Wang, G., & Zou, W. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2011.47 · Cited by 356
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A Review
Pinter, M., Jain, R. K., & Duda, D. G. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.3381 · Cited by 339
Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl‐p53 pathway
Zhou, Y., Que, K., Zhang, Z., Yi, Z. J., Zhao, P. X., You, Y., Gong, J., & Liu, Z. (2018) · Cancer Medicine · doi:10.1002/cam4.1670 · Cited by 336
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
Gabrielson, A., Wu, Y., Wang, H., Jiang, J., Kallakury, B., Gatalica, Z., Reddy, S., Kleiner, D., Fishbein, T., Johnson, L., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0110 · Cited by 299
Zhang, B., Yang, Y., Yi, J., Zhao, Z., & Ye, R. (2021) · Journal of Periodontal Research · doi:10.1111/jre.12912 · Cited by 253
Clark, T., Maximin, S., Meier, J., Pokharel, S., & Bhargava, P. (2015) · Current Problems in Diagnostic Radiology · doi:10.1067/j.cpradiol.2015.04.004 · Cited by 246
Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis
Handa, P., Thomas, S., Morgan-Stevenson, V., Maliken, B. D., Gochanour, E., Boukhar, S., Yeh, M. M., & Kowdley, K. V. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0318-108r · Cited by 217
Apolipoproteins, lipids and risk of cancer
Borgquist, S., Butt, T., Almgren, P., Shiffman, D., Stocks, T., Orho‐Melander, M., Manjer, J., & Melander, O. (2016) · International Journal of Cancer · doi:10.1002/ijc.30013 · Cited by 209
Myeloid cells in hepatocellular carcinoma
Wan, S., Kuo, N., Kryczek, I., Zou, W., & Welling, T. H. (2015) · Hepatology · doi:10.1002/hep.27867 · Cited by 158
Yuan, Y., Chen, Y., Peng, T., Li, L., Zhu, W., Liu, F., Liu, S., An, X., Luo, R., Cheng, J., et al. (2019) · Clinical Science · doi:10.1042/cs20190672 · Cited by 158
Inhibition of Ferroptosis Attenuates Acute Kidney Injury in Rats with Severe Acute Pancreatitis
Ma, D., Li, C., Jiang, P., Jiang, Y., Wang, J., & Zhang, D. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06225-2 · Cited by 113
Hu, X., Cai, X., Ma, R., Fu, W., Zhang, C., & Du, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28518 · Cited by 102
ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3
Li, Y.-L., Wu, L., Zeng, L., Zhang, Z., Wang, W., Zhang, C., & Lin, N. (2020) · Oncogene · doi:10.1038/s41388-020-01428-3 · Cited by 102
Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells
Takano, S., Yoshitomi, H., Togawa, A., Sogawa, K., Shida, T., Kimura, F., Shimizu, H., Tomonaga, T., Nomura, F., & Miyazaki, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210951 · Cited by 93
PDSS2 Inhibits the Ferroptosis of Vascular Endothelial Cells in Atherosclerosis by Activating Nrf2
Yang, K., Song, H., & Yin, D. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001030 · Cited by 83
Berbée, J. F. P., van der Hoogt, C. C., Kleemann, R., Schippers, E. F., Kitchens, R. L., van Dissel, J. T., Bakker‐Woudenberg, I. A. J. M., Havekes, L. M., & Rensen, P. C. N. (2006) · The FASEB Journal · doi:10.1096/fj.05-5639fje · Cited by 82
Honokiol induces ferroptosis in colon cancer cells by regulating GPX4 activity.
Guo, C., Liu, P., Deng, G., Han, Y., Chen, Y., Cai, C., Shen, H., Deng, G., & Zeng, S. (2021) · PubMed · Cited by 80
Ko, H., Wang, Y., Fong, W., Chi, M., Chi, K., & Kao, S. (2014) · Thoracic Cancer · doi:10.1111/1759-7714.12117 · Cited by 79
Ren, H., Chen, Z., Yang, L., Xiong, W., Yang, H., Xu, K., Zhai, E., Ding, L., He, Y., & Song, X. (2019) · Cancer Management and Research · doi:10.2147/cmar.s192529 · Cited by 75
M2-like polarization of THP-1 monocyte-derived macrophages under chronic iron overload
Kao, J., Wang, S., Ho, L.-W., Huang, S., Lee, C., Lee, M.-S., Yang, R., & Shieh, J. (2020) · Annals of Hematology · doi:10.1007/s00277-020-03916-8 · Cited by 64
Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer
Yi, J., Ren, L., Wu, J., Li, W., Zheng, X., Du, G., & Wang, J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.07.59 · Cited by 56
Declining disease burden of HCC in the United States, 1992–2017: A population‐based analysis
Han, J., Wang, B., Liu, W., Wang, S., Chen, R., Chen, M., & Fu, Z. (2022) · Hepatology · doi:10.1002/hep.32355 · Cited by 50
Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro
Su, W., Sun, L., Yang, S., Zhao, H., Zeng, T., Wu, W., & Wang, D. (2018) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22158 · Cited by 48
Aerbajinai, W., Ghosh, M. C., Liu, J., Kumkhaek, C., Zhu, J., Chin, K., Rouault, T. A., & Rodgers, G. P. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018026070 · Cited by 44
Li, L., Shen, L., Ma, J., Zhou, Q., Li, M., Wu, H., Wei, M., Zhang, D., Wang, T., Qin, S., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00451 · Cited by 25
Cited by
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 890
Ferroptosis: principles and significance in health and disease
Chen, F., Kang, R., Tang, D., & Liu, J. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01564-3 · Cited by 285
Kohlhepp, M. S., Liu, H., Tacke, F., & Guillot, A. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1129831 · Cited by 27
Self-citation
Metadata
- Authors
- Hao, X., Zheng, Z., Liu, H., Zhang, Y., Kang, J., Kong, X., Rong, D., Sun, G., Sun, G., Liu, L., Yu, H., Tang, W., & Wang, X.
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2022-10
- Volume
- 56
- Pages
- 102463
- ISSN
- 2213-2317 (ISSN-L)
- OpenAlex
- W4294191660
- Cited by
- 314
- References
- 38
- FWCI
- 20.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.